Related Experiment Video
Updated: Jan 9, 2026
08:55
The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
17.1K
Cancer-Associated Cachexia in the Era of Obesity
Joyce Cristina Ferreira de Resende1, Márcia Fábia Andrade1, Fabiana Amaral Ferreira1
1Cancer Metabolism Research Group, Laboratory of Experimental Surgery (LIM 26), Department of Surgery, Faculdade de Medicina da Universidade de São Paulo, HC-FMUSP, São Paulo 01246-903, Brazil.
International Journal of Molecular Sciences
|December 11, 2025
Summary
Obesity and cancer cachexia, though opposites, share inflammation and metabolic changes. Understanding these common pathways, especially involving white adipose tissue, is key for developing new treatments.
Area of Science:
- Metabolic disorders
- Inflammation research
- Adipose tissue biology
Background:
- Obesity and cancer cachexia present contrasting body mass index (BMI) profiles.
- Both conditions involve significant metabolic alterations driven by inflammation and adipose tissue dysfunction.
- Chronic inflammation and altered fat metabolism are common underlying factors.
Purpose of the Study:
- To explore shared inflammatory and metabolic pathways in obesity and cancer cachexia.
- To investigate the specific role of white adipose tissue (WAT) in these conditions.
- To highlight the therapeutic potential of understanding common mechanisms.
Main Methods:
- Literature review focusing on inflammatory and metabolic pathways.
- Analysis of the role of white adipose tissue (WAT) in both obesity and cancer cachexia.
- Synthesis of current research on shared mechanisms.
Main Results:
- Both obesity and cancer cachexia exhibit increased inflammatory cytokines (e.g., TNF-α, IL-6).
- Shared inflammatory signaling contributes to metabolic dysregulation and energy imbalance.
- White adipose tissue (WAT) plays a crucial, though differential, role in both conditions.
Conclusions:
- Obesity and cancer cachexia share fundamental inflammatory and metabolic pathways.
- Targeting these common mechanisms, particularly WAT involvement, may offer novel therapeutic avenues.
- Further research into these shared pathways is essential for effective management strategies.
Related Concept Videos
01:24Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
02:53Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
221
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
221
01:21Overview of Protein Metabolism
3.5K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
3.5K
03:03mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
01:21Cancer Survival Analysis
629
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
629